These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 5529915)
1. The Eaton collaborative study of levodopa therapy in parkinsonism: a summary. Keenan RE Neurology; 1970 Dec; 20(12):Suppl:46-65. PubMed ID: 5529915 [No Abstract] [Full Text] [Related]
2. The Eaton Collaborative Study of levodopa therapy in parkinsonism: a summary. Keenan RE Neurology; 1970 Dec; 20(12):46-59. PubMed ID: 5531294 [No Abstract] [Full Text] [Related]
3. Levodopa in parkinson's disease--Australian collaborative trial. Selby G Med J Aust; 1973 Mar; 1(12):577-85. PubMed ID: 4700544 [No Abstract] [Full Text] [Related]
4. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease. Muenter MD Neurology; 1970 Dec; 20(12):6-13. PubMed ID: 4924343 [No Abstract] [Full Text] [Related]
5. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease. Muenter MD Neurology; 1970 Dec; 20(12):Suppl:6-13. PubMed ID: 4921587 [No Abstract] [Full Text] [Related]
6. L-DOPA treatment for Parkinsonism: analysis of functional improvement. Jonas S Arch Phys Med Rehabil; 1971 Dec; 52(12):560-2. PubMed ID: 5136441 [No Abstract] [Full Text] [Related]
7. The clinical use of levodopa in the treatment of Parkinson's disease. McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056 [No Abstract] [Full Text] [Related]
8. MK 486 and levodopa in treatment of Parkinsonism. Lieberman AN; Derby BM; Feigenson J; Goodgold A; Nesbitte J; Resurreccion EC; Valdivia F Dis Nerv Syst; 1973; 34(4):167-71. PubMed ID: 4711885 [No Abstract] [Full Text] [Related]
9. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders. Timberlake WH Neurology; 1970 Dec; 20(12):31-5. PubMed ID: 4924342 [No Abstract] [Full Text] [Related]
11. Double-blind comparison of levodopa and procyclidine in parkinsonism, with illustrations of levodopa-induced movement disorders. Timberlake WH Neurology; 1970 Dec; 20(12):Suppl:31-5. PubMed ID: 4921586 [No Abstract] [Full Text] [Related]
12. [Use of L-DOPA in the therapy of parkinsonism]. D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A; Tedeschi G Rass Int Clin Ter; 1971 Feb; 51(4):193-221. PubMed ID: 4930734 [No Abstract] [Full Text] [Related]
13. Effectiveness and limitations of long-term levodopa therapy in Parkinsonism. Celesia GG; Barr AN Wis Med J; 1970 Oct; 69(10):227-9. PubMed ID: 5472626 [No Abstract] [Full Text] [Related]
14. [L-dopa and parkinsonism. A preliminary report]. Pakkenberg H Ugeskr Laeger; 1969 May; 131(22):959-60. PubMed ID: 5793628 [No Abstract] [Full Text] [Related]
15. L-dopa and amantadine in the therapy of parkinsonism. Weeth JB; Shealy CN; Mercier DA Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055 [No Abstract] [Full Text] [Related]
17. Metabolism and clinical assessment of L-dopa in parkinsonism. Ericsson AD; McCann D; Sharpless N; Reveno W Neurology; 1970 Apr; 20(4):402. PubMed ID: 4935027 [No Abstract] [Full Text] [Related]
18. The modifying influence of L-dopa on the physical therapy program in Parkinson's disease. Blonsky ER; Minnigh EC Prog Phys Ther; 1970; 1(1):55-74. PubMed ID: 5523796 [No Abstract] [Full Text] [Related]
19. Levodopa therapy for Parkinson's disease. A first-year experience with outpatients in private practice. McFarland HR Mo Med; 1971 Nov; 68(11):843-7. PubMed ID: 5096631 [No Abstract] [Full Text] [Related]
20. [Clinical effect of L-DOPA and electromyographic study of Parkinsonism]. Sato G; Ito H; Handa Y; Takahashi I; Iijima K No To Shinkei; 1971 Mar; 23(3):325-32. PubMed ID: 5107821 [No Abstract] [Full Text] [Related] [Next] [New Search]